❤️‍🩹 Eczema, Endometriosis, and Fish Farms - This Week in Health

Hi there 👋 

Welcome to this week’s edition of HealthHack, where we explore the latest innovations shaping how you prevent illness, manage conditions, and access cutting-edge treatments.

This week, new digital therapies are making it easier to manage chronic conditions like endometriosis, while hospitals are embracing AI-driven IT systems to improve patient care. Elsewhere, breakthroughs in programmable cell depletion could change how we treat cancer and autoimmune diseases, while biotech is stepping in to protect our food supply by tackling infections in fish farms.

And in a development that feels like science fiction, scientists are unlocking the potential of genetic engineering to make biotech production scalable, paving the way for faster and more efficient drug manufacturing.

From digital health to next-gen biotech, the future of healthcare is smarter, more accessible, and built around you.

Let’s dive in. 🚀

🩸 A New Era in Endometriosis Care

Endometriosis affects millions of women worldwide, but accessing effective treatments remains a challenge. Lyv Healthcare is tackling this issue head-on with Lyv Endo®, a digital therapy designed to provide non-drug solutions to alleviate symptoms and improve quality of life. By integrating this platform into employer health programs and social security systems, Lyv aims to reduce the post-diagnosis struggle for countless women. Read more

🧬 Next-Gen Bioproduction: Making Biotech Scalable

Enduro Genetics is changing the game for biotech manufacturing. Using advanced genetic engineering, the company has unlocked new ways to produce high-value biomaterials at scale—something that could transform industries from medicine to sustainable agriculture. The potential applications are vast, from developing more efficient drug production methods to making bio-based products more accessible. Read more

🛑 Programmable Cell Depletion: A New Tool in Disease Treatment

Akribion Therapeutics is pioneering programmable cell depletion, a method that allows scientists to selectively remove harmful cells in the body. This innovation could lead to better treatments for cancers, autoimmune disorders, and other conditions where rogue cells cause damage. Imagine a future where targeted therapies eliminate diseased cells without harming the rest of your body. Read more

🐟 Keeping Our Food Supply Safe with Biotech

Koa Biotech is addressing a critical but often overlooked issue: infections in fish farms. These outbreaks can devastate aquaculture and impact the food supply. By developing targeted biotech solutions, Koa is making it easier to prevent and manage diseases in farmed fish—helping to ensure healthier seafood for everyone. Read more

🏥 A Smarter, More Connected Hospital Experience

Avelios Medical is bringing hospitals into the digital age with modern IT systems designed to streamline patient care, reduce administrative burden, and improve overall hospital efficiency. From better data management to AI-assisted diagnostics, this upgrade could mean shorter wait times, more accurate diagnoses, and improved patient outcomes. Read more

🌿 Soothing Eczema with Innovative tech

Eczema sufferers know the struggle of relentless itching and discomfort. Cosi Care is addressing this with an innovative cooling and vibration-based device designed to provide instant relief without the need for medication or creams. By disrupting the itch-scratch cycle, this technology could help millions manage their symptoms more effectively and comfortably. Read more

🩺 Early Cancer Detection at Your Fingertips

Dxcover is revolutionising early cancer detection with its advanced diagnostic technology. The company is working on rapid, non-invasive tests that can identify cancer at its earliest stages—when treatment is most effective. A future where cancer is detected with a simple test, long before symptoms appear, might be closer than we think. Read more

🧠 New Hope for Mental Health and Neurorehabilitation

Neurocare Group is at the forefront of personalised mental health and neurostimulation therapies. Their innovative approach combines technology with clinical expertise to treat conditions like depression, ADHD, and PTSD in a more targeted way. As mental health challenges continue to rise, solutions like these could reshape the way we think about treatment. Read more

🌀 Reimagining Parkinson’s Treatment

Herantis Pharma is working on disease-modifying therapies for Parkinson’s disease, focusing on treatments that go beyond symptom relief to slow or stop disease progression. With promising early-stage trials, their approach could offer new hope for millions affected by this neurodegenerative condition. Read more

❤️‍🩹 Advancing Treatments for Blood Clot-related Conditions

Thrombo-inflammatory diseases, which involve dangerous blood clots and inflammation, pose serious risks to patients with cardiovascular conditions. Aplagon is working on novel antithrombotic and anti-inflammatory therapies that could revolutionise the way these diseases are treated—potentially leading to safer, more effective solutions for patients at risk of strokes, heart attacks, and other clot-related complications. Read more

Whether it’s digital therapies, biotech breakthroughs, or AI-driven healthcare, innovation is reshaping the future of medicine—and your healthcare experience.

The next generation of treatments is not just about doctors and scientists; it’s about giving you access to better care, earlier diagnoses, and more personalised treatments.

Until then, stay curious, stay inspired, and stay well!

The HealthHack Team